Acquisition (Tables)

3 Months Ended

Mar. 31, 2017

Preliminary Purchase Price Consideration

The purchase price was calculated as follows:



Fair value of RestorGenex shares outstanding	$	19,546,000
Estimated fair value of RestorGenex stock options outstanding	1,321,000
Estimated fair value of RestorGenex warrants outstanding	384,000
CVRs – RES-440 product candidate	10,000
Total purchase price	$	21,261,000

Schedule of Recognized Identified Assets Acquired and Liabilities Assumed

The following table summarizes the allocation of the purchase price to the assets acquired and liabilities assumed as of the acquisition date:



Cash and cash equivalents	$	8,500,602
Prepaid expenses and other assets	195,200
Property and equipment	57,531
Intangible assets	9,600,000
Goodwill	6,929,258
Accrued liabilities	(377,432		)
Deferred tax liability	(3,644,159		)
Net assets acquired	$	21,261,000

Pro Forma Information

The pro forma financial information is not necessarily indicative of the results of operations as they would have been had the transactions been effected on the assumed date.



	Three Months Ended March 31, 2016
	Three Months Ended March 31, 2016
Net revenues	$	—
Net loss	(4,655,944		)
Basic and diluted loss per share	$	0.47